Global Age-related Macular Degeneration Market 2016-2020

Publisher Name :
Date: 28-Sep-2016
No. of pages: 99
Inquire Before Buying

About AMD

AMD is the degeneration or disintegration of the eye's macula. The macula is a small area of the retina that is responsible for the central vision. AMD can be classified into two types: dry and wet macular degenerations. When the tiny abnormal blood vessels begin growing toward the macula, it develops into wet AMD. Dry AMD occurs when small, yellowish deposits called drusen start accumulating beneath the macula. While some treatments are available for wet AMD; there is no treatment available at the moment for dry AMD.

This analyst forecast the global age-related macular degeneration (AMD) market to grow at a CAGR of 7.37% during the period 2016-2020.

Covered in this report

This report covers the present scenario and the growth prospects of the global age-related macular degeneration (AMD) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of AMD.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

The report, Global Age-Related Macular Degeneration (AMD) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

Bayer HealthCare

F. Hoffmann-La Roche

Novartis

Regeneron Pharmaceuticals

Other prominent vendors

Alcon

Allergan

Adverum Biotechnologies

Bausch + Lomb

Gilead Sciences

Iconic Therapeutics

Lpath

Neurotech Pharmaceuticals

Ohr Pharmaceutical

Opthea

Ophthotech

PanOptica

Pfizer

Promedior

QLT

Quark

Resolvyx Pharmaceuticals

RXi Pharmaceuticals

Sagent Pharmaceuticals

Santen Pharmaceuticals

Sanwa Kagaku Kenkyusho

Market driver

Increasing reimbursement benefits for AMD drugs

For a full, detailed list, view our report

Market challenge

Availability of alternative therapies

For a full, detailed list, view our report

Market trend

Novel treatment approaches for developing AMD drugs

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Global Age-related Macular Degeneration Market 2016-2020

Table of Contents

PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Key buying criteria
PART 06: AMD: Overview
Understanding the disease
Stages of AMD
Etiology
Signs and symptoms
Diagnosis
Management
PART 07: Pipeline portfolio
PART 08: Market landscape
Market overview
PART 09: Market analysis of major drugs
Lucentis
Eylea
Avastin
Five forces analysis
PART 10: Market segmentation by type
Global wet AMD market
Market overview
Global dry AMD market
Market overview
PART 11: Market segmentation by ROA
IV
Intravitreal
PART 12: Geographical segmentation
AMD market in Americas
AMD market in EMEA
AMD market in APAC
PART 13: Market drivers
Increase in aging population
Increasing reimbursement benefits for AMD drugs
Increase in diagnosis rate
High patient and physician satisfaction
PART 14: Impact of drivers
PART 15: Market challenges
Gap in patient demand vs. ophthalmology expert supply
Increasing use of off-label drugs
Availability of alternative therapies
PART 16: Impact of drivers and challenges
PART 17: Market trends
Novel treatment approaches for developing AMD drugs
Increased research grants, initiatives, and programs
Use of combination therapies
PART 18: Vendor landscape
Competitive scenario
Other prominent vendors
PART 19: Key vendor analysis
Bayer HealthCare
F. Hoffmann-La Roche
Novartis
Regeneron Pharmaceuticals
PART 20: Appendix
List of abbreviations

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Leading drugs for AMD
Exhibit 03: Novel opportunities for AMD market: Entry of squalamine
Exhibit 04: Global AMD market snapshot
Exhibit 05: Key buying criteria for AMD drugs
Exhibit 06: Key buying criteria for global AMD market 2015
Exhibit 07: Impact of key customer segments on global AMD market 2015
Exhibit 08: Stages of AMD
Exhibit 09: Risk factors for AMD
Exhibit 10: Diagnosis of AMD
Exhibit 11: Product portfolio of current AMD therapies
Exhibit 12: Share of pipeline molecules in global AMD market
Exhibit 13: Prevalence of AMD 2000 and 2050 (millions)
Exhibit 14: Global AMD market snapshot: Developed and emerging markets 2015
Exhibit 15: Factors influencing the global AMD market 2015
Exhibit 16: Global AMD market 2015-2020 ($ billions)
Exhibit 17: Impact of drivers and challenges of global AMD market
Exhibit 18: Opportunity analysis of global AMD market by type
Exhibit 19: Timeline of key regulatory approvals of Lucentis
Exhibit 20: YoY growth and revenue generated from sales of Lucentis 2013-2015 ($ billions)
Exhibit 21: Timeline of key regulatory approvals and filings of Eylea
Exhibit 22: YoY revenue and growth rate of Eylea 2012-2015 ($ billions)
Exhibit 23: Five forces analysis
Exhibit 24: Global AMD market: Segmentation by type 2015-2020
Exhibit 25: Global AMD market segmentation: Growth cycle analysis
Exhibit 26: Competitive landscape of wet AMD drugs
Exhibit 27: Global wet AMD market 2015-2020 ($ billions)
Exhibit 28: Opportunity analysis of global dry AMD market
Exhibit 29: Global dry AMD market 2015-2020 ($ millions)
Exhibit 30: Segmentation of global AMD market by ROA 2015
Exhibit 31: Global AMD market: Geographical outlook (2015-2020)
Exhibit 32: Global AMD market: Geography outlook 2015
Exhibit 33: Revenue/growth outlook in different countries/regions 2015
Exhibit 34: Global AMD market segmentation by region: Market growth lifecycle analysis 2015
Exhibit 35: AMD market revenue by geography 2015-2020 ($ billions)
Exhibit 36: Opportunity analysis of AMD market in Americas
Exhibit 37: AMD market in Americas 2015-2020 ($ billions)
Exhibit 38: Opportunity analysis of AMD market in EMEA
Exhibit 39: AMD market in EMEA 2015-2020 ($ billions)
Exhibit 40: Opportunity analysis of AMD market in APAC
Exhibit 41: Prevalence rates of AMD in APAC countries 2015
Exhibit 42: AMD market in APAC 2015-2020 ($ billions)
Exhibit 43: Percentage of Americans with vision loss
Exhibit 44: Distribution of population aged 60 years and over (millions)
Exhibit 45: Impact of drivers
Exhibit 46: Impact of drivers and challenges
Exhibit 47: Geographical presence of key vendors
Exhibit 48: Company portfolio analysis in global AMD market 2016-2020
Exhibit 49: Bayer HealthCare: Profile
Exhibit 50: Bayer HealthCare: Metrics analysis
Exhibit 51: Bayer HealthCare: Growth strategy matrix
Exhibit 52: Bayer HealthCare: Opportunity assessment
Exhibit 53: F. Hoffmann-La Roche: Profile
Exhibit 54: F. Hoffmann-La Roche: Metrics analysis
Exhibit 55: F. Hoffmann-La Roche: Growth strategy matrix
Exhibit 56: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 57: Novartis: Specialty ophthalmic segmentation by revenue 2015
Exhibit 58: Novartis: Profile
Exhibit 59: Novartis: Metrics analysis
Exhibit 60: Novartis: Growth strategy matrix
Exhibit 61: Novartis: Opportunity assessment
Exhibit 62: Regeneron Pharmaceuticals: Profile
Exhibit 63: Regeneron Pharmaceuticals: Metrics analysis
Exhibit 64: Regeneron Pharmaceuticals: Growth strategy matrix
Exhibit 65: Regeneron Pharmaceuticals: Growth opportunity assessment
  • Ophthalmology Drug Development Pipeline Review, 2016
    Published: 01-Dec-2016        Price: US 3995 Onwards        Pages: 633
    Ophthalmology disorders are associated with the eyes and visual system. If left untreated, serious long-term co-morbidities such as diabetes, and particularly blindness, can arise. Although there are a number of treatments approved in ophthalmology, there are currently no curative therapies for any of these indications. In particular, there are strong unmet needs within age-related macular degeneration and glaucoma, which can lead to blindness if not adequately treated. Although there......
  • Global Conjunctivitis Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 30-Nov-2016        Price: US 3480 Onwards        Pages: 118
    Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.Conjunctivitis is more commonly referred to as pink eye. The whites of the eyes appear pink or red when the conjunctiva (the transparent membrane which lines part of the eyeball) becomes inflamed or infected......
  • Global Optic Neuritis Market Research Report 2016
    Published: 17-Nov-2016        Price: US 2900 Onwards        Pages: 103
    Notes: Production, means the output of Optic Neuritis Revenue, means the sales value of Optic Neuritis This report studies Optic Neuritis in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Sicor Societa' Italiana Corticosteroidi S.R.L - Allergan Pharmaceuticals Ireland......
  • Macular Edema - Pipeline Review, H2 2016
    Published: 16-Nov-2016        Price: US 2000 Onwards        Pages: 63
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Macular Edema - Pipeline Review, H2 2016, provides an overview of the Macular Edema (Ophthalmology) pipeline landscape.Macular edema is swelling or fluid retention in a specialized part of the retina called the macula. Symptoms of macular edema include blurred or wavy central vision and/or colors appear changed. There are many causes of macular edema. It is frequently associated with diabetes, where damaged bl......
  • Diabetic Retinopathy - Pipeline Review, H2 2016
    Published: 16-Nov-2016        Price: US 2000 Onwards        Pages: 237
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Retinopathy - Pipeline Review, H2 2016, provides an overview of the Diabetic Retinopathy (Metabolic Disorders) pipeline landscape.Diabetic retinopathy is a complication of diabetes that affects the eyes. Diabetic retinopathy symptoms may include spots or dark strings floating in your vision (floaters), blurred vision, fluctuating vision, vision loss and difficulty with color perception. The predisposi......
  • Dry (Atrophic) Macular Degeneration - Pipeline Review, H2 2016
    Published: 16-Nov-2016        Price: US 2000 Onwards        Pages: 136
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dry (Atrophic) Macular Degeneration - Pipeline Review, H2 2016, provides an overview of the Dry (Atrophic) Macular Degeneration (Ophthalmology) pipeline landscape.Dry atrophic macular degeneration is generally characterized by a slow but progressive visual loss. This is characterized by yellow spots under the retina, called drusen, which are accumulations of metabolic waste products. Symptoms include blurred o......
  • Retinal Vein Occlusion - Pipeline Review, H2 2016
    Published: 09-Nov-2016        Price: US 2000 Onwards        Pages: 76
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinal Vein Occlusion - Pipeline Review, H2 2016, provides an overview of the Retinal Vein Occlusion (Ophthalmology) pipeline landscape.Retinal vein occlusion is a blockage in one of the veins returning blood flow from the retina. The retina is where images are converted to nerve signals. The primary symptom of retinal vein occlusion is a sudden painless change in vision. Predisposing factors are atherosclero......
  • Global Assistive Technologies for Visual Impairment Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 08-Nov-2016        Price: US 3480 Onwards        Pages: 117
    Assistive Technologies for Visual Impairment is an umbrella term that includes assistive, adaptive, and rehabilitative devices for people with Visual Impairment and also includes the process used in selecting, locating, and using them. Scope of the Report: This report focuses on the Assistive Technologies for Visual Impairment in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market bas......
  • Global Ophthalmics Partnering 2010-2016: Deal trends, players and financials
    Published: 01-Nov-2016        Price: US 2995 Onwards        Pages: 500
    "Delivery of this report will take 1-3 days after purchase." Global Ophthalmics Partnering 2010 to 2016 provides the full collection of Ophthalmics disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. Trends in Ophthalmics partnering deals Financial deal terms for headline, upfront and royalty by stage of development Ophthalmics partnering agreement structure Ophthalmics partnering cont......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs